期刊文献+

我院治疗系统性红斑狼疮药物使用分析 被引量:1

An analysis of systemic lupus erythematosus drug in out-patient clinic of our hospital
在线阅读 下载PDF
导出
摘要 目的了解目前医院治疗系统性红斑狼疮药物的使用情况。方法选取中山大学孙逸仙纪念医院1466张治疗系统性红斑狼疮处方进行分析。结果我院治疗系统性红斑狼疮药物使用频率前三位依次是泼尼松(44.2%)、羟氯喹(41.6%)和硫唑嘌呤(26.5%)。糖皮质激素类(82.4%)使用频率最高。结论治疗系统性红斑狼疮应采取综合性治疗措施,结合个体化给药方案,以最小药物剂量达到最佳治疗效果。 Objective To investigate the situation of systemic lupus erythematosus ( SLE) drug of the outpatient. Methods The 1466 prescriptions for outpatients in our hospital were sampled. Results The first 3 places in frequency of use of the drugs were aligned to prednisone( 44. 2% ) ,hydroxychloroquine( 41. 6% ) and azathioprine ( 26. 5% ) . Corticosteroids was used most ( 82. 4% ) . Conclusion Treatment of systemic lupus erythematosus should adopt comprehensive treatment,combined with personalized medicine,with minimum doses to achieve the best effect.
作者 辛莉 陈楚雄
出处 《中国现代药物应用》 2010年第21期20-21,共2页 Chinese Journal of Modern Drug Application
关键词 处方分析 系统性红斑狼疮 药物分析 Prescription analysis Systemic lupus erythematosus:Pharmaceutical analysis
  • 相关文献

参考文献7

  • 1陈灏珠.实用内科学.人民卫生出版社,2006:802.
  • 2Sibilia J.Treatment of systemic lupus erythematosus in 2006.Joint Bone Spine,2006,73(6):591-598.
  • 3张江林,黄烽.羟氯喹的药理作用及在风湿性疾病中的应用[J].解放军药学学报,2000,16(2):85-88. 被引量:37
  • 4Levy RA,Vilela VS,Cataldo MJ,et al.Hydroxy chloroquine(HCQ) in lupus pregn-ancy:double -blind placebo-conerythematosus.Lupus,2004,13(8):601.
  • 5Breedveld FC,Dayer JM.Leflunomide:mode of action in thetreatment of rheum-Atoid arthritis.Ann Rheum Dis,2000,59:841-849.
  • 6Tam LS,Li EK,Wong CK,et al.Double-blind,randomized,placebo-controlled pilot study of leflunomide in systemic lupuserythematosus.Lupus,2004,13:601-604.
  • 7马丽.系统性红斑狼疮的个体化治疗(VCD)[J].中华临床医师杂志(电子版),2008,2(6):56-56. 被引量:3

二级参考文献27

  • 1[1] Tett SE,Cutler DJ,Day RO.Bioavailability of hydroxychloroquinetablets assessed with deconvolution techniques[J].J Pharm Sic,1992;81:155
  • 2[2] McChesney EW. Animal toxicity and pharmacokinetics of hydroxychlo-roquine sulfate[J].Am J Med,1983;75(suppl 1):11
  • 3[3] Hurst NP, French JK, Bell AL,et al.Differential effects of mepacrine,chloroquine and hydroxychloroquine on superoxide anion generation,phospholipid methylation and arachidonic acid release by human blood monocytes[J].Biochem Pharmacol,1986;35:3083
  • 4[4] Wallace DJ,Linker-Israeli M,Metzger AL,et al.The relevance ofantimalarial therapy with regard to thrombosis,hypercholesterolemia,and cytokines in SLE.Lupus[J] 1993;2(suppl 1):S13
  • 5[5] Munro R,Morrison E,McDonald AG,et al.Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis[J].Ann Rheum Dis,1997;56(6):374
  • 6[6] Weissmann G.Lysosomes[J].N Engl J Med,1965;273:1141
  • 7[7] Ciak J,Hahn FE.Chloroquine:mode of action[J].Science,1966;151:347
  • 8[8] Fox RI.Mechanism of action of hydoxychloroquine as an antirheumatic drug[J].Semin Arthritis Rheum,1993;23(suppl 1):82
  • 9[9] Fox RI,Kang HL.Mechanism of action of antimalarial drugs:inhibition of antigen processing and presentation[J].Lupus,1993;2(suppl 1):S9
  • 10[10] Meng XW,Feller JM,Ziegler JB,et al.Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine[J].Arthritis Rheum,1997 May;40(5):927

共引文献59

同被引文献18

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部